In the ACH2.0 perspective, the observed limited symptoms of AD in the current transgenic models of the disease are caused mainly by the ISR triggered by intraneuronal AβPP-derived iAβ accumulated over the critical threshold. This evidence concerns the gene APP and Alzheimer disease.